Skip to content

Clinical trials

Axial Spondyloarthritis trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Axial Spondyloarthritis Country / region: China Clear all

15 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20161
20182
20193
20203
20221
20231
20241
20251
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9
Recruiting4
Not yet recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
UCB Biopharma SRL3
Chinese PLA General Hospital2
Genrix (Shanghai) Biopharmaceutical Co., Ltd.2
The First Affiliated Hospital of Xiamen University2
AbbVie1
China-Japan Friendship Hospital1
Jiangsu HengRui Medicine Co., Ltd.1
Novartis Pharmaceuticals1
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.1
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Axial Spondyloarthritis15
Spondylitis, Ankylosing7
Non-Radiographic Axial Spondyloarthritis4
Spondylarthritis3
Autoimmune Diseases1

Trials

Showing 26 to 15 of 15. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.